DK1732567T3 - Anvendelse af et phenothiazin-derivat til at forhindre og/eller behandle höretab - Google Patents

Anvendelse af et phenothiazin-derivat til at forhindre og/eller behandle höretab

Info

Publication number
DK1732567T3
DK1732567T3 DK05744629T DK05744629T DK1732567T3 DK 1732567 T3 DK1732567 T3 DK 1732567T3 DK 05744629 T DK05744629 T DK 05744629T DK 05744629 T DK05744629 T DK 05744629T DK 1732567 T3 DK1732567 T3 DK 1732567T3
Authority
DK
Denmark
Prior art keywords
prevent
hearing loss
phenothiazine derivative
treat hearing
treat
Prior art date
Application number
DK05744629T
Other languages
Danish (da)
English (en)
Inventor
Bernadette Pignol
Jean-Luc Puel
Serge Auvin
De Lassauniere Pierre Chabrier
Jing Wang
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0403203A external-priority patent/FR2867979B1/fr
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK1732567T3 publication Critical patent/DK1732567T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B21/00—Thiazine dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05744629T 2004-03-29 2005-03-25 Anvendelse af et phenothiazin-derivat til at forhindre og/eller behandle höretab DK1732567T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0403203A FR2867979B1 (fr) 2004-03-29 2004-03-29 Nouvelle application therapeutique d'un derive de la phenothiazine
FR0406404 2004-06-14
PCT/FR2005/000713 WO2005092345A1 (fr) 2004-03-29 2005-03-25 Utilisation d’un derive de la phenothiazine pour la prevention et/ou le traitement de la perte d’audition

Publications (1)

Publication Number Publication Date
DK1732567T3 true DK1732567T3 (da) 2009-02-09

Family

ID=34968214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05744629T DK1732567T3 (da) 2004-03-29 2005-03-25 Anvendelse af et phenothiazin-derivat til at forhindre og/eller behandle höretab

Country Status (14)

Country Link
US (1) US7696197B2 (ja)
EP (1) EP1732567B1 (ja)
JP (1) JP5066444B2 (ja)
AR (1) AR048195A1 (ja)
AT (1) ATE410169T1 (ja)
CA (1) CA2560988A1 (ja)
DE (1) DE602005010222D1 (ja)
DK (1) DK1732567T3 (ja)
ES (1) ES2315868T3 (ja)
HK (1) HK1101545A1 (ja)
PL (1) PL1732567T3 (ja)
PT (1) PT1732567E (ja)
RU (1) RU2377992C2 (ja)
WO (1) WO2005092345A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1954288B1 (fr) * 2005-10-21 2012-08-01 Ipsen Pharma Derives d'amidine et leurs applications a titre de medicament
FR2892415B1 (fr) * 2005-10-21 2007-11-30 Sod Conseils Rech Applic Derives d'amidine et leurs applications a titre de medicament
FR2898274B1 (fr) * 2006-03-07 2008-10-03 Sod Conseils Rech Applic Composition contenant des derives d'amidine ou de carboxamide et des steroides a titre de medicament
US8460639B2 (en) * 2008-12-25 2013-06-11 Canon Kabushiki Kaisha Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell
GB2467561A (en) * 2009-02-06 2010-08-11 Summit Corp Plc Dual calpain-ROS inhibitors
US20150150843A1 (en) * 2012-05-21 2015-06-04 Randall T. Peterson Cardioprotective compounds, their use with chemotherapy, and methods for identifying them
JP6542192B2 (ja) 2013-03-14 2019-07-10 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． Ｂｍｐ阻害剤およびその使用方法
RU2529700C1 (ru) * 2013-04-12 2014-09-27 Закрытое Акционерное Общество "Клинский институт охраны и условий труда "ОЛС-Комплект" Способ профилактики профессиональной потери слуха
US10513521B2 (en) 2014-07-15 2019-12-24 The Brigham And Women's Hospital, Inc. Compositions and methods for inhibiting BMP
WO2016033615A1 (en) * 2014-08-29 2016-03-03 Sound Pharmaceuticals Incorporated Methods of screening for drugs to prevent noise-induced hearing loss
JP6999896B2 (ja) 2017-09-21 2022-01-19 学校法人慶應義塾 音響外傷難聴モデル動物の作製方法及びそれにより作製される音響外傷難聴モデル動物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149177A0 (en) * 1999-11-05 2002-11-10 Sod Conseils Rech Applic Novel heterocyclic compounds and their use as medicines
FR2816509B1 (fr) * 2000-11-15 2004-02-06 Sod Conseils Rech Applic Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene
FR2863268B1 (fr) 2003-12-09 2006-02-24 Sod Conseils Rech Applic Nouveaux derives du 2-hydroxytetrahydrofuranne et leur application a titre de medicaments

Also Published As

Publication number Publication date
JP5066444B2 (ja) 2012-11-07
RU2377992C2 (ru) 2010-01-10
EP1732567A1 (fr) 2006-12-20
HK1101545A1 (en) 2007-10-18
WO2005092345A1 (fr) 2005-10-06
JP2007530640A (ja) 2007-11-01
US20080275034A1 (en) 2008-11-06
PT1732567E (pt) 2009-01-14
PL1732567T3 (pl) 2009-04-30
CA2560988A1 (fr) 2005-10-06
ES2315868T3 (es) 2009-04-01
RU2006138035A (ru) 2008-05-10
DE602005010222D1 (de) 2008-11-20
EP1732567B1 (fr) 2008-10-08
AR048195A1 (es) 2006-04-05
ATE410169T1 (de) 2008-10-15
US7696197B2 (en) 2010-04-13

Similar Documents

Publication Publication Date Title
DK1732567T3 (da) Anvendelse af et phenothiazin-derivat til at forhindre og/eller behandle höretab
DK1793855T4 (da) Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
DK3067066T3 (da) Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
DK1824475T3 (da) Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1771201T3 (da) Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DK1771446T3 (da) Azaindolinhibitorer af MTP og APOB
DK1853271T3 (da) Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
DK1755743T3 (da) Beta-hydroxybutyrat og derivater til behandling af depression og angst
DK2463283T3 (da) Kondenserede heterocykliske phenylamidoforbindelser til forebyggelse og behandling af glucokinase-medierede sygdomme
DK1871738T3 (da) N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelse
DK3321359T3 (da) Variante former af uratoxidase og anvendelse deraf
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
DK1934179T3 (da) Fremgangsmåder og mellemprodukter
DK1856374T3 (da) Sammensætning og fremgangsmåde til fremstilling af et støttemiddel
BRPI0807495A2 (pt) Adjuvantes e métodos de emrpego dos mesmos
DK1744589T3 (da) Høreindretning og tilsvarende fremgangsmåde
DK1720866T3 (da) Fremgangsmåde
DK2308900T3 (da) Immunogene sammensætninger og fremgangsmåder til anvendelse
DK2084151T3 (da) Substituerede dihydropyrazoloner til behandling af kardiovaskulære og hæmatologiske sygdomme
DK1922307T3 (da) Heterocykliske inhibitorer af MEK og fremgangsmåder til anvendelse heraf
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf